EcoDrugPlus

Apoptosis Regulator Bcl-2-Like

Ensembl ID : ENSOKIG00005005854
Gene Symbol: LOC109909828
2 Cross references
161 Possible Orthologues:

Apoptosis Regulator Bcl-2-Like

Ensembl ID : ENSOKIG00005002041
Gene Symbol: LOC109899300
3 Cross references
161 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSOKIG00005033650
Gene Symbol: APEX1
3 Cross references
208 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s-Type-Like

Ensembl ID : ENSOKIG00005003110
Gene Symbol: LOC109896866
2 Cross references
191 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSOKIG00005003273
Gene Symbol: ALOX5A
1 Cross references
220 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSOKIG00005041978
Gene Symbol: ALOX5A
1 Cross references
219 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSOKIG00005022186
Gene Symbol: LOC109883149
3 Cross references
194 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein-Like

Ensembl ID : ENSOKIG00005043004
Gene Symbol: LOC109874055
3 Cross references
194 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSOKIG00005035847
Gene Symbol: LOC109882634
3 Cross references
191 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOKIG00005010783
Gene Symbol: AVPR1A
3 Cross references
187 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOKIG00005001876
Gene Symbol: AVPR1A
3 Cross references
139 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSOKIG00005014948
Gene Symbol: AVPR1A
3 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).